Overcoming Obesity

In today’s world where there are countries struggling to overcome famine and shortage of food there are others who are increasingly getting populated with obese people. Obesity is one of the key problem many are facing across the world. It is a result of either improper lifestyle and food habits or is completely hereditary. In either case one needs to check on their consumption pattern and modify there lifestyle accordingly. Many awareness activities are also being undertaken by health institutions to deal with it. A systematic way to start losing weight is by bringing about a change in the daily lifestyle. Self-check on the intake of caloriies, regular physical activity, setting targets, stimulus control, giving non-food rewards and most importantly preventing relapses are some of the strategic ways to control weight.

As we can classify Obesity as one of the social problems, companies are resorting to restricited advertising by showcasing its products to a limited audience so that people who are more likely to get obese on consuming the products are ruled out of the system. With the increasing awareness companies are coming up with products that are consumer friendly. Like the Coca-Cola Company came up with Coke Zero & Diet Coke in comparison to its existing calorious regular coke.

With nearly half the world suffering from the weight problem the obesity market is expected to increase at a compound annual growth rate (CAGR) of more than 35% from 0.4 billion U.S. dollars in 2012 to some 8.4 billion in 2022. More and more companies coming up weight reducing drugs, new thearapies to tackle obesity and many other personal consultations and programmes. This in turn is boosting the growth of the Obesity Industry at large.

The Global Markets Direct’s- Obesity – Pipeline Review, H1 2015 provides an all-inclusive report on the different treatments developed and under process for curing obesity. It has a detailed analysis of drug target, mechanism of action (MoA), route of administration (RoA) and molecule type together with the latest updates. It includes a detailed analysis of the key players in the market together with all the R&D work undertaken by them. In includes the details about their product- the ones that have been launched and ones that are yet to be launched.

Visit Detailed Report @ http://www.rnrmarketresearch.com/obesity-pipeline-review-h1-2015-market-report.html .

The Booming Market of Carbon Fibre

The speed at which the Carbon Fibre Industry is growing it is sure to be one of the most profitable industry in the years to come. The sales of carbon fibre tow is expected to increase from $1.6 billion in 2011 to $4.5 billion in 2020. The overall The global demand for carbon fibre tow will grow 46,000 tonnes in 2011 to 140,000 tonnes in 2020. The material consists of strong crystalline filaments of a few microns of carbon atoms, that makes carbon fibre one of the strongest fibre. Carbon Fiber Reinforced Plastic (CFRP) is a compound, consisting of various carbon fibers and thermosetting resins.

The main application of these materials includes Aerospace & Defense, Wind Energy, Automobile, Sports Equipment, Marine, Civil, and Molding & Compound. Carbon Fiber is also used heavily in producing industrial components that is used in the Electronic and Pharmaceutical industry. Initially the materials was used only in these industries but with passage of time Carbon Firbre is now being used for a lot many commercial purposes. Some of these are listed as below:

  • Compressed natural gas storage and transportation
  • Fuel Cells
  • Construction of light weight infrastructure ie, earthquake resistant
  • A host of oil exploration services such as deep sea drilling, drill pipes, etc.

Carbon Fibre is also being used for the production of high performing cars along with a series of other cars. One of the most valuable applicaton of Carbon Fibre has been in the field of superlight carbon fibre wheels. It has rendered the entire experience of riding a car smooth with an improved mechanical grip, and oil efficiency, better steering, handling and response, along with a host of other benefits.

Few of the top companies owned almost  60% of the global carbon fiber capacity together like Toray, Teijin, Mitsubishi Rayon, Germany SGL and Formosa Plastics. Starting 2014 there were a number of Chinese undertaking in the market and many of the foreign companies started procuring the T300 carbon fiber manufactured by China. But the Chinese industry faced a downfall as the operating cost started shooting up compared to the cost of carbon fibre that faced a steep downfall. The adverse market condition also let to the downfall of many start-ups which were initiated in the Chinese market round this time. One of the companies who survived the market conditions were Jiangsu Hengshen Fiber Material and Zhongfu Shenying Carbon Fiber who achieved an output of above 1,000 tons and successfully did a decent business. However this market has been growing ever since at a good double digit rate. The rising demand and widespread product application is sure to keep the market up and moving.

For a detailed information on demand-supply pattern of the market, competition, price analysis and development trend of the global carbon fiber industry, and an insight of operations and businesses of nine overseas carbon fiber manufacturers; as well as the developments of 28 carbon fiber producers in Mainland China one can refer to the report on Global and China Carbon Fiber Industry Report, 2014-2017 (http://www.rnrmarketresearch.com/global-and-china-carbon-fiber-industry-report-2014-2017-market-report.html).

Visit our paid press release on “Carbon Fiber”

http://www.prnewswire.com/news-releases/carbon-fiber-industry-2016—2019-forecasts-for-china-and-global-markets-284566501.html .

Incentivising Research & Development Activities

Research and Development (R&D) is the base of innovation, competitiveness and economic performance. Any company or a country that seeks to be ahead of its competitors need to invest heavily in setting up an active R&D wing. In today’s world everything is technology oriented.  People are coming up with new ideas, products and newer ways of getting a work done easily almost every day. Under such a circumstance it is essential that all such positive ideas are tapped in the right direction. But there is no denying that for doing this there is a huge requirement of resource and a strong back-up by the government of the state.

Different organizations and countries have different incentives for facilitating R&D work. Some of these are quite lucrative to attract companies for setting up its R&D work in that region. The Organization for Economic Co-operation and Development (OECD) countries, are highly acclaimed for promoting R&D activities by offering various incentives. A big company has a lot of cash flow that can be invested in R&D work but for a small and medium-size enterprise incentives provided by different countries/organizations is very vital. Incentive offerings under this head can be broadly classified as- tax incentives & non-tax incentives. Through tax incentives benefits or tax exemptions are allowed to undertakings for carrying out a R&D activity. This form of incentive is very popular and usually sort after however for availing it, it is important that the company is doing a profitable business and not struggling for survival. A slightly less popular one is the non-tax incentive. This is one where the company is allowed subsidies or grants instead of a tax exemption.

Some of the companies have a high R&D support are Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Greece, Germany, Hungary, Iceland, Ireland, Israel, Italy, Japan, South Korea, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom and United States. It is important that a company understands the definition of R&D as described by each of the countries as different countries have different requirements and restrictions. In order to avoid any ambiguity in terms of expectations  and ensure a smooth work enforcement the company should thorough go through and understand the definition and clauses for setting up its R&D unit in that particular country. Also the company should have a knowledge of how to benefit by availing maximum incentives. As some of these incentives save nearly 40-45% of corporate taxes of the companies and also save a lot of expenses to a great extent.

Visit Detailed Report @ http://www.rnrmarketresearch.com/research-and-development-rd-incentives-databook-market-report.html .

Global Cystic Fibrosis Market Propelled by Technological Advancement

With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian or African descent. The global market for cystic fibrosis is expected to grow at a compound annual growth rate of 32.50 percent during the period from 2014 and 2019. In recent years, there has been greater awareness about cystic fibrosis and its treatment. This has in turn fueled the growth of the global cystic fibrosis market. Some other factors which are propelling the growth of the market are better healthcare facilities, technological advancement and greater emphasis on research and development.

The global market for cystic fibrosis can be segmented on the basis of molecule type, route of administration, dosage form and geographical regions. On the basis of molecule type, the global cystic fibrosis can be segmented into biologics and small molecules. According to route of administration, the market can be segmented into oral, parenteral and topical. By dosage form, the market can be segmented into solid and liquid. Key players in the global cystic fibrosis market are Novartis, Actavis, Vertex Pharmaceuticals, F. Hoffmann-La Roche, Johnson & Johnson, Novo Nordisk, and Abbot Pharmaceuticals. Major pharmaceutical companies are increasing their R&D activities and coming up with innovative drugs. This is in turn contributing to the growth of the global market for cystic fibrosis.

In North America, an ever-increasing aging population and better awareness of the condition, has made it the dominant region in the global cystic fibrosis market. In the coming years, Asia-Pacific, particularly China and India are expected to fastest growing market for cystic fibrosis. However, some factors such as high cost of treatment and increase in the complexity of cystic fibrosis are restraining the growth of the market. In the coming years, a number of drugs which are administered for the treatment of cystic fibrosis will lose their patent. This will also expected to act as a restrain for the growth of the market. Increasing research and development for the launch of new medications and introduction of various medications in the antibiotic segment is going to contribute to the growth of the market.

Explore the latest market research reports on global cystic fibrosis market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics

Bright Prospects Ahead for the SONAR Systems and Technology Market

With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the SONAR systems and technology market was valued at 3.41 billion USD. By 2020, the market is expected to reach a value of 4.90 billion USD, growing at a compound annual growth rate of 6.22 percent. Some of the factors which are fueling the growth of the SONAR systems and technology market are advancement in digital signal processing and progress in anti-submarine warfare techniques.

The SONAR systems and technology market can be segmented on the basis of type, application, component, software, acoustic frequency, and geographical regions. By type, the SONAR systems and technology market can be segmented into active SONAR and passive SONAR. By component, the market can be segmented into transmitter, receiver, synchronizer, projector, hydrophone, beamforming processor and display 1. On the basis of software, the market can be segmented into signal processing algorithms/acoustic processing software, 3d seabed visualization software, software defined SONAR, software defined sonobuoy receiver, data management system, multi-function workstations, SONAR data logger for SONAR acquisitions, echo analysis, mosaicking and contact analyzer. On the basis of application, the market can be segmented into commercial, military, and scientific. Among different types of SONARs, passive SONAR is forecasted to be the maximum revenue generator in the coming years.

Key players in the market are Lockheed Martin, Thales Underwater Systems Ltd., Ultra Electronics, Raytheon, and Kongsberg Maritime. The dominant companies in the SONAR systems and technology market are Thales Underwater Systems and Ultra Electronics and together they account for around 40 percent of the total market share. Currently, North America is the dominant market in the SONAR systems and technology market. However, Asia-Pacific is forecasted to have high-growth in the coming years. Some of the factors which are fueling the growth of the market are increasing demand for SONAR systems and technology in the medical sector, high demand for multibeam SONAR systems, and growing demand for sonobuoys in defense operations. However, environmental issues and risks involved with emitted radiation are challenges to the growth of the market.

Explore the latest market research reports on SONAR systems and technology market @ http://www.rnrmarketresearch.com/reports/public-sector/defense/naval-vessels-warships

Increase in Surgical Procedures Propelling the Anesthesia Drugs Market

With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the anesthesia drugs market in the US is expected to reach a value of 3 billion USD. Growth in the market for anesthesia drugs is affected by factors such as regulation of anesthesia drugs in different states and reaction to such drugs.

The US market for anesthesia drugs can be segmented on the basis of drug type. According to drug type, the anesthesia drugs in United States can be segmented into general inhalation anesthesia drugs, general intraveneous anesthesia drugs, and local anesthesia drugs. The general anesthesia drugs market can be further subdivided into propofol, ketamine, methohexital sodium, fospropofol disodium, pentobarbital, etomidate, fentanyl, and benzodiazepines class (diazepam and midazolam). Local anesthesia drugs market is segmented into articaine, bupivacaine, lidocaine, mepivacaine, and Prilocaine. Increasing demand for anesthesia service and increasing aging population are fueling the market for anesthesia drugs market in the United States. Intraveneous anesthesia drugs accounts for the largest market share. In 2011, the general anesthesia market in the US was valued at 2 billion USD and it is the fastest growing segment in the country. In the general anesthesia segment, ketamine is the preferred drug and it is expected to grow at a steady rate in the coming years.

Key players in the anesthesia drugs market in the United States are Abbot Laboratories, Baxter International, AstraZeneca Plc, and Endo Health Solutions Inc. However, in recent years there are a number of new and emerging companies who are making their presence felt in the market. There are different routes of administering anesthesia to patients. These include inhalation and intravaneous methods. Mask inhalation, laryngeal mask, endotracheal administration, and controlled respiration are some of the modes of administering anesthesia through inhalation. Regulation of anesthesia drugs in different states and recall of certain drugs due to their side effects are some of the challenges which are plaguing the growth of the market. With rise in the number of emergency surgical procedures and increase in cosmetic surgery, the market for anesthesia drugs in the United States is forecasted to grow in the future.

Explore the latest market research reports on anesthesia drugs market in the US @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/anesthesia-drugs

Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies

The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market for water treatment chemicals is also expected to surge in the coming years. With increased economic growth and growth in different industries, there has been high demand for water treatment chemicals in the Asia-Pacific region. Emerging economies such as Brazil, China and India are going to drive the growth in the global water treatment chemicals market.

The global water treatment chemicals market can be segmented on the basis of type of product, applications, and geographical areas. By product type, the global market for water treatment chemicals can be segmented into corrosion inhibitor, scale inhibitor, coagulants and flocculants, chelating agents, biocides & disinfectants, anti-foaming agents, and pH adjusters and stabilizers. By application, the market can be segmented into industrial and municipal water. The industrial water segment can be further categorized into power generation, food & beverage, chemical processing, pulp & paper, oil & gas, and metal & mining. Corrosion inhibitors and scale inhibitors are the largest segment in the global water treatment chemicals market. Industrial water treatment segment was the major consumer of water treatment chemicals. With healthy economic growth and stringent government and environmental regulations, there is going to be a high demand for water treatment chemicals from developing economies in the coming years.

Key players in the global water treatment chemicals market are AzkoNobel N.V., GE Water & Process Technologies, BASF SE, Nalco-Ecolob Company, Air Products and Chemicals Inc., Ashland Inc., Lonz Group Ltd., BWA Water Additives UK Limited, Kurita, The Dow Chemical Company, and Kemira. Manufacturers of water treatment chemicals are coming up with new product launches to expand their reach in the market. In the coming years, the demand for biocides and disinfectants is expected to decline with rising use of disinfection equipment. Regulations regarding wastewater management and municipal water standards have become more stringent in most countries. This is going to promote greater use of water treatment chemicals which is in turn going to propel the growth of the global water treatment chemicals market.

Explore the latest market research reports on water treatment chemicals market @ http://www.rnrmarketresearch.com/reports/materials-chemicals/chemicals/specialty-chemicals/water-treatment-chemicals

Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market

With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in the last couple of years. This has led to an increase in the global market for allergy diagnostics. In 2014, the global diagnostics market was valued at 1.228 billion USD. By 2019, the market is expected to reach a value of 2.23 billion USD growing at a compound annual growth rate of 12.67 percent. Currently North America is the largest market for allergy diagnostics.

Key players in the global allergy diagnostics market are Alerchek Inc., Hitachi Chemicals Diagnostics, Siemens Healthcare, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Biomerieux, Hob Biotech Group, Hycor Biomedical, Lincoln Diagnostics, and Stallergenes. The global market for allergy diagnostics can be segmented on the basis of allergen type, end-user, product and geographical areas. On the basis of allergen, the market can be segmented into food allergens, inhaled allergens and other allergens. Both Food allergens and inhaled allergens can be further categorized into animal origin food allergens and plant origin food allergens. By end-user, the global market for allergy diagnostics market can be segmented into diagnostic laboratories, academic research institutes, hospitals, and other end users. By product, the allergy diagnostics market can be segmented into assay kits and consumables.

Some of the key drivers in the global allergy diagnostics market are growth in the IVD market, increasing healthcare expenditure and rising number of allergic diseases such as rhinitis and asthma. The global allergy diagnostics market is also driven by the increase in aging population, increasing access to medical insurance, and increase in laboratory automation. However, there are certain restraints to the growth in the market, which includes stringent regulatory policies for medical devices, and requirement of high capital investment. High degree of consolidation is also going to act as an entry barrier for new entrants in the global allergy diagnostics market. With increasing incidences of lifestyle diseases, the global market for allergy diagnostics is forecasted to increase in the future.

Explore the latest market research reports on global allergy diagnostics market @ http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd/laboratory-instrumentation

Global Video Surveillance Market Driven by Increasing Demand for Security

The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global video surveillance market was valued at 13.98 billion. By 2020, the market is forecasted to reach a value of 42.06 billion, growing at a compound annual growth rate of 16.97 percent during the period from 2014 to 2020. Some of the factors which are driving the growth in the market are implementation of video analytics, infrastructure growth in emerging economies, and greater need for physical security.

Key players in the video surveillance market are Bosch Security Systems Inc., Avigilon Corporation, Panasonic System Networks Co Ltd., Dahua Technologies Co. Ltd., Honeywell Security Group, Pelco by Schneider Electric, Axis Communications AB, Flir Systems Inc., Hangzhou Hikvision Digital Technology Co. Ltd., and Mobotix AG. The global market for video surveillance can be segmented on the basis of system, application sector, hardware, services offered, software and geographical region. On the basis of system, the global market for video surveillance can be categorized into analog video surveillance system and internet protocol (IP) video surveillance system. Based on application sector, the market can be segmented into commercial, industrial, infrastructure, institutional, and residential. According to hardware used, the market can be categorized as monitors, camera, storage, and accessories. North America is the largest IP video surveillance market, followed by Europe.

The increasing need for greater security is one of the main drivers in the global video surveillance market. With technological improvements made in IP cameras and better graphical user interfaces from video management systems, the video surveillance market is expected to grow at a steady pace in the future. The rising popularity of IP based video surveillance cameras that provide better video quality is also going to propel the growth of the global video surveillance market. With high economic growth in emerging nations such as India and China, there will be an increase in installations of surveillance systems. This will in turn increase the growth of the market. However issues about privacy are a major concern that is retaining the growth in the global market for video surveillance.

Exploring the latest market research reports on global video surveillance market @ http://www.rnrmarketresearch.com/reports/information-technology-telecommunication/electronics/consumer-electronic/video-equipment

Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry

With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the nutraceutical industry. The rising demand for hard gelatin, nongelatin capsules and pullatan capsules in the pharmaceutical and nutraceutical market is also fueling the growth in the industry. By 2019, the global market for empty capsules market is expected to reach a value of 1.82 billion. An emerging trend in the empty capsule market is the growing demand for nongelatin capsules.

Capsules are used extensively in various therapeutic applications such as vitamins and dietary supplements, cardiovascular therapy drugs, antibiotic drugs etc. With growth in the pharmaceutical industry, the global market for empty capsules is also expected to grow in the future. The global empty capsule market is segmented on the basis of product type, therapeutic application, source of raw material and end user. By product type, the empty capsule market is categorized as hard gelatin capsules and non-gelatin based capsules. On the basis of raw material, the market can be segmented into pig skin gelatin, bovine hide gelatin, bone gelatin, Hydroxy Propyl Methy Cellulose (HPMC), and pullulan and starch material. By end user, the market can be segmented into pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. According to therapeutic application, the global market for empty capsules can be segmented into vitamins and dietary supplements, cardiac therapy drugs, antibiotics and antibacterial drugs, antianemic preparations, cough and cold preparations, antacid and antiflatulent preparations, anti-inflammatory and antirheumatic drugs, and other therapeutic preparations.

Key players in the global empty capsules market are Medi-Caps Limited, Roxlor LLC, Bright Pharma Industry Co. Ltd, Capscanada Corporation, ACG Worldwide, Qualicaps, Co. Ltd., Capsugel, Suheung Co. Ltd., Snail Pharma Industry Co. Ltd., and Sunil Healthcare Ltd. The US is the leader in the global market for empty capsules market and accounts for more than one-fourth of the overall market share. However, in the coming years, Asia-Pacific is expected to have the highest growth opportunity. Rising levels of income in emerging economies, growing aging population, government initiatives in healthcare and increased access to healthcare are some of the factors which are going to positively impact the pharmaceutical and nutraceutical market. This is in turn going to propel the global market for empty capsules market in the future.

Explore the latest market research report on empty capsules market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals